Follow
Jesse Popov
Jesse Popov
British Columbia Cancer Agency / University of British Columbia
Verified email at mail.mcgill.ca
Title
Cited by
Cited by
Year
Soret coefficients for aqueous polyethylene glycol solutions and some tests of the segmental model of polymer thermal diffusion
J Chan, JJ Popov, S Kolisnek-Kehl, DG Leaist
Journal of solution chemistry 32, 197-214, 2003
832003
Transition from nanodomains to microdomains induced by exposure of lipid monolayers to air
O Coban, J Popov, M Burger, D Vobornik, LJ Johnston
Biophysical journal 92 (8), 2842-2853, 2007
372007
Chemical mapping of ceramide distribution in sphingomyelin-rich domains in monolayers
J Popov, D Vobornik, O Coban, E Keating, D Miller, J Francis, ...
Langmuir 24 (23), 13502-13508, 2008
322008
Multivalent Rituximab Lipid Nanoparticles as Improved Lymphoma Therapies: Indirect Mechanisms of Action and In Vivo Activity
J Popov, AI Kapanen, C Turner, R Ng, C Tucker, G Chiu, R Klasa, ...
Nanomedicine 6 (9), 1575-1591, 2011
302011
Selective recognition of rituximab-functionalized gold nanoparticles by lymphoma cells studied with 3D imaging
A Weiss, TC Preston, J Popov, Q Li, S Wu, KC Chou, HM Burt, MB Bally, ...
The Journal of Physical Chemistry C 113 (47), 20252-20258, 2009
262009
Psoralen and Coumarin Photochemistry in HSA Complexes and DMPC Vesicles
L Chen, O Rinco, J Popov, N Vuong, LJ Johnston
Photochemistry and photobiology 82 (1), 31-37, 2006
142006
Unique therapeutic properties and preparation methodology of multivalent rituximab-lipid nanoparticles
J Popov, R Gilabert-Oriol, MB Bally
European Journal of Pharmaceutics and Biopharmaceutics 117, 256-269, 2017
82017
J. Solution Chem
J Chan, JJ Popov, S Kolisnek-Kehl, DG Leaist
42003
Multivalent monoclonal antibodies as improved cancer therapies: proof-of-concept and mechanistic studies using rituximab-lipid nanoparticles
J Popov
University of British Columbia, 2012
12012
Expression of TCF3 target genes defines a subclass of diffuse large B-cell lymphoma characterized by up-regulation of MYC target genes and poor clinical outcome following R …
K Tyryshkin, A Moore, D Good, J Popov, S Crocker, MJ Rauh, T Baetz, ...
Leukemia & Lymphoma 64 (1), 119-129, 2023
2023
An Approach Using Liposomal Monoclonal-Antibody Constructs to Study the Therapeutic Effects of Target Hyper-Crosslinking
J Popov, A Thomas, C Turner, G Chiu, MB Bally
Mol. Biol. Cell 22 (19), 3555 (Suppl.: 2008 Late Abstracts p.98), 2011
2011
Ceramide modulates the structure of" raft" domains in model membranes: An AFM study
I Ira, JJ Popov, LJ Johnston
BIOPHYSICAL JOURNAL 88 (1), 72A-72A, 2005
2005
Lima ECD Liu J Lu Z Ma N
H Maiato, HW Chang, J Cheon, G Chikh, G Chiu, R Cingolani, ...
Developing an Innovative Nanopharmaceutical for Cancer Treatment
J Popov
The system can't perform the operation now. Try again later.
Articles 1–14